R. Duca

发表

MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis

A. De Siervi, E. Lacunza, P. L. Farré, 2021, International journal of molecular sciences.

CTBP 1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis

K. Gardner, A. Siervi, P. D. Luca, 2018 .

MiR-19b-3p and miR-101-3p as potential biomarkers for prostate cancer diagnosis and prognosis.

A. De Siervi, P. L. Farré, R. Duca, 2021, American journal of cancer research.

CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice

A. De Siervi, P. De Luca, G. Gueron, 2019, Cell Death & Disease.

Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients

A. De Siervi, K. Gardner, E. Lacunza, 2022, Frontiers in Oncology.

Hsa-miR-1-2/miR-133a-1 Cluster Expression Silencing by DNA Hypermethylation Triggers Oncogenes Contributing to Prostate Cancer Aggressiveness

K. Gardner, A. Siervi, E. Lacunza, 2021 .

CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice

K. Gardner, A. De Siervi, P. De Luca, 2019, Cell Death and Disease.

Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development

K. Gardner, A. De Siervi, E. Lacunza, 2020, Molecular oncology.

CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis

K. Gardner, A. De Siervi, P. De Luca, 2018, Oncotarget.

miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome

A. De Siervi, E. Lacunza, P. L. Farré, 2023, International journal of molecular sciences.